SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following positive earnings and news of a significant AI lease deal, with the community buzzing about a potential short squeeze. A price target increase from Roth Capital is adding fuel to the fire, as investors discuss the company's prospects in AI infrastructure and data centers. Some community members are comparing it to other high-growth stocks and discussing strategies around calls and puts, while others are considering it for long-term investment.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending due to a strategic partnership focused on developing quantum-resistant chips for U.S. defense applications, igniting discussions about future government contracts. The community is actively evaluating the company's growth potential relative to other quantum computing stocks. Many investors are describing LAES as undervalued with potential for a significant upward trajectory.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals is trending following news of positive clinical data for their QRX003 treatment, specifically in a pediatric peeling skin syndrome study. The community is actively discussing the stock's low float and potential for a short squeeze, drawing comparisons to other recent low-float biotech runners. Some traders caution about dilution and the company's history, while others remain bullish, citing the potential of the treatment and market opportunity.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending due to discussions around a potential short squeeze, fueled by its high short interest and Google's stake in the company, as well as its shift towards AI data centers. Community members are closely watching resistance levels and anticipating a breakout, comparing it to other stocks in the sector and discussing potential price targets. The stock's technical ratings and the broader context of data center shortages are also contributing to the increased interest.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASPI is trending due to high volume and speculation about a potential news leak, with community members discussing a possible short squeeze and potential catalysts. Bullish sentiment is fueled by upcoming milestones like the QLE spinoff, while others express skepticism and caution about the stock's volatility. Traders are actively monitoring price action and technical indicators, awaiting further company updates.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company ($ABAT) is trending as the stock price increases, spurring excitement among long-term investors who have been holding shares for several years and are now seeing significant gains. Community members are actively discussing potential price targets and the impact of upcoming news, particularly around the PFS (Pre-Feasibility Study). The company's positioning in lithium recycling, especially with potential government support and China's export controls, is also a key talking point.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARA is trending as discussions revolve around its potential to catch up with other miners like CLSK and IREN, with some expressing frustration over its underperformance and management. Community members are debating whether its current valuation reflects its Bitcoin holdings and future AI prospects. Short interest remains high, fueling speculation about a potential squeeze.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending as traders discuss its potential in the quantum computing sector, particularly compared to peers like $IONQ and $RGTI. The community highlights Infleqtion's existing contracts, partnership with NVIDIA, and a potential for significant upside, while some anticipate a near-term run to $30+ and compare it to previous high-flying SPACs. Chatter also mentions upcoming events and presentations, further fueling interest.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as investors react to recent news, including a new multi-launch agreement with Japan's iQPS. The community is actively discussing the potential impact of this deal, along with speculation about upcoming catalysts like the Neutron launch and potential government contracts. Some traders caution about short-term overvaluation, while long-term bulls remain confident in the company's growth prospects.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is surging, fueled by speculation around a potential ETF and positive technical indicators, leading to renewed interest in the crypto asset. The community is actively discussing price targets and potential breakouts, while also debating whether this rally will be sustained. Some traders are pointing to Litecoin's historical performance relative to Bitcoin, suggesting it is undervalued.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IceCure Medical to Attend the 2025 Maxim Growth Summit

IceCure Medical to Attend the 2025 Maxim Growth Summit IceCure Medical to Attend the 2025 Maxim Growth Summit PR Newswire CAESAREA, Israel, Oct. 9, 2025 IceCure recently achieved a significant...

ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment

IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.

Shares of IceCure Medical (ICCM) went as high as $1.4 on Friday afternoon before paring back gains after the U.S. Food and Drug Administration granted marketing authorization for ProSense, a minimally invasive cryoablation treatment.ProSense is for patients aged 70 and over with early-stage low-risk breast cancer and treated with adjuvant endocrine therapy. It is the first and only medical device to receive FDA marketing authorization for the local treatment of breast cancer, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.icecure-medical.com/news-events/press-releases/detail/191/icecure-medicals-prosense-cryoablation-granted-fda-marketing-authorization-for-treatment-of-low-risk-breast-cancer-in-women-aged-70-and-above-significant-development-in-giving-women-with-breast-cancer-minimally-invasive-care">stated</a>.During the ProSense cryoablation procedure, a doctor injects local anesthesia and uses ultrasound imaging to guide a small cryoprobe, a thin hollow needle, into the breast tumor. Once the cryoprobe is placed, liquid nitrogen creates extremely cold temperatures, which destroy the breast tumor by creating an ice ball around the targeted tissue.The approval of the treatment was based on data, including a multi-centre clinical trial with 194 patients. Only 3.1% of patients with hormone receptor-positive and HER2-breast cancer treated locally with cryoablation and endocrine therapy experienced local recurrence of breast cancer within five years after treatment in the study, IceCure said.The company, however, stated that the FDA has requested it conduct a post-market surveillance study to generate additional data. The post-market study is expected to include approximately 400 patients, IceCure said.IceCure lists several benefits to its treatment, including maintenance of breast shape, a short, outpatient procedure, and reduced recovery time. The majority of adverse events identified in studies were swelling, bruising, hematoma, skin burn, and postoperative pain, which were mild in severity, it added.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ICCM">ICCM stock</a> soared from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:576/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_03_at_2_00_01_PM_png_a1d54603d1.webp" alt="ICCM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Oct. 03, 2025 | Source: Stocktwits" width="576" height="61"><figcaption>ICCM's Sentiment Meter and Message Volume as of 2:00 p.m. ET on Oct. 03, 2025 | Source: Stocktwits</figcaption></figure>ICCM stock is down 4% this year but up by about 74% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rocket-pharma-stock-gets-price-target-cut-after-withdrawing-fda-application-for-rare-bone-marrow-disorder-gene-therapy/chCuqQ5R3Qm">Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

IceCure Medical’s Treatment For Low-Risk Breast Cancer In Women Aged 70 And Over Receives FDA Approval

The company stated that the FDA has requested it conduct a post-market surveillance study to generate additional data.

Equity

IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates

IceCure Medical (ICCM) delivered earnings and revenue surprises of +200.00% and -34.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates

Viatris (VTRS) delivered earnings and revenue surprises of +10.71% and +2.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates

Labcorp (LH) delivered earnings and revenue surprises of +5.07% and +1.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Misses Revenue Estimates

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation...

IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision

IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates...

IceCure Files for Regulatory Approval of ProSense Cryoablation System in China

IceCure Files for Regulatory Approval of ProSense Cryoablation System in China IceCure Files for Regulatory Approval of ProSense Cryoablation System in China PR Newswire CAESAREA, Israel, Jan. 27...

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Icecure Medical Ltd

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

ICCM
Icecure Medical Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ICCM News

ICCMIcecure Medical Ltd